Success Metrics

Completion Rate
0%(0/1)
Active Trials
3(60%)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Terminated(1)

Detailed Status

Recruiting3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

not_yet_recruiting120%
recruiting360%
terminated120%

Recent Activity

3 active trials
Showing 5 of 5
not_yet_recruiting

Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology

NCT07550049
recruiting

ctDNA in Cutaneous Squamous Cell Carcinoma

NCT06875609
recruiting

Localized Leiomyosarcoma Biomarker Protocol

NCT04925089
recruitingnot_applicable

Multimodal Study of the Human Brain Epilepsy Tissue

NCT06022055
terminated

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

NCT03108885

Clinical Trials (5)

Showing 5 of 5 trials
NCT07550049

Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology

Not Yet Recruiting
NCT06875609

ctDNA in Cutaneous Squamous Cell Carcinoma

Recruiting
NCT04925089

Localized Leiomyosarcoma Biomarker Protocol

Recruiting
NCT06022055Not Applicable

Multimodal Study of the Human Brain Epilepsy Tissue

Recruiting
NCT03108885

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

Terminated

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5